Episode 83 Part 1

The Disease Signal Shows Up Before Symptoms

Ilya Burkov (1/4)

“Once you start measuring a joint or a tissue, you realize that the signal of disease is in the data long before anyone feels a symptom.”

Show notes

“Once you start measuring a joint or a tissue, you realize that the signal of disease is in the data long before anyone feels a symptom.”

Ilya Burkov is Global Head of Scientific AI & Healthcare at Nebius. Ilya's parents had one rule for every childhood ambition, astronaut, fireman, chef: get a foundation first, then choose. He took it seriously. Sports year round, science projects, Scouts trips, and around ten A levels, because biology, law, electronics, and further maths all seemed worth knowing. Where did the road really start? A hospital, he says, where he volunteered as a teenager, brought tea to long-term patients, and kept noticing that homes had Dysons while wards had old fans.

That question about outdated hospital tech sent him hunting for a field that fused medicine with engineering, right as biomedical engineering degrees first appeared in the UK. He calls the course a Frankenstein of chemical, electronic, and mechanical engineering stitched onto anatomy and patient care. A master's in nanomedicine followed, just as stem cells and drug delivery were breaking through. His dissertation asked whether cartilage damage in osteoarthritis could be reversed, and that question pulled him toward the imaging biomarkers that flag disease long before symptoms.

It ends with a stroke of luck: an interview he took out of curiosity while planning a move to France. Two hours later, the phone rang. Professor Ken Poole, the one interviewer he'd genuinely enjoyed, would be his PhD supervisor at Cambridge.

Explore the conversation

Continue with the resources, organizations, and people discussed in this episode.

About Ilya Burkov

Ilya Burkov is the Global Head of Scientific AI & Healthcare at Nebius. With a background spanning biomedical engineering, nanomedicine, and musculoskeletal research at Cambridge, Ilya previously led healthcare and life sciences business development and AI initiatives at Amazon Web Services (AWS) before joining Nebius to build high-performance AI cloud infrastructure tailored for the life sciences.

Transcript

Search the conversation or jump directly to a chapter.

Read the full transcript

Don’t Miss Out. Get Episodes in Your Inbox.

Subscribe to the TBSP newsletter to stay up to date on new episodes. Get founder insights and biotech startup stories that show how breakthrough science becomes scalable startups, directly in your inbox.

Peach, the podcast mascot